Janumet Efficacy
Janumet Safety Trials
Janumet vs other DPP-4
Janumet in Special population
Composit-R
100

How much does Janumet decrease A1c from a baseline of 11%?

3.6%

100

What patient catergory did the TECOS trial include?

Cardiovascular Disease patients

100

What is the inhibition rate of Janumet on the DPP4 enzyme?

97%

100

How safe and effective is Janumet in Elderly patients (>65 yo)

Safety and effectiveness of Januvia in elderly were comparable to those seen in younger patients

100

What were the 2 study arms of the Composit-R study?

Dapagliflozin 10mg and Januvia 100 mg

200

In what stages of diabetes is Janumet the most effective?

All stages, but the highest A1c drop is in newly diagnosed patients

 

200

What is the median duration of diabetes in the patients included in the TECOS study?

11.6 years

200

What is the only DPP4i that has a high selectivity on the DPP4 enzyme?

Sitagliptin

200

In which renal impairment populations is sitagliptin studied?

Mild, moderate, severe and end stage on dialysis

200

What was the difference in the A1c reduction?

0.15%

300

What is the most studied DPP4?

Sitagliptin

300

In the TECOS trial, sub-analyses were published for which patient category?

Renally impaired patients, Heart failure patients, Elderly and fracture risks

300

What is the difference in the A1c reduction between Januvia and Vildagliptin?2-

20%

300

What is the new renal adjustment needed for Januvia?

GFR >50 mL/min = 100 mg daily

GFR >30 mL/min to <50 mL/min = 50 mg daily

GFR<30 mL/min =25 mg daily

300

What is the propotion of patients who achieved HbA1c <7% in the 2 arms?

Januvia 43%

Dapagliflozin 27%

400

What did the Odyssee study show?

Less hypoglycemia, less body weight change, patients maintained treatment longer (almost 2 years longer)

400

What did TECOS trial show regarding Pancreatitis and Pancreatic cancer

Both uncommon

400

What is the inhibition rate of Linagliptin, saxagliptin and allogliptin on the DPP4 enzyme?

80%

400

What do you think are the advantages of keeping or giving sitagliptin if you want to initiate insulin in your type 2 diabetic patient?

Less hypoglycemia, lower dose of insulin required and more A1c control

400

What population was studied in the Composit R trial?

Mild renally impaired patients with more than 25 years of diabetes

M
e
n
u